Trials / Completed
CompletedNCT01188122
Optimal Endotracheal Cuff Pressure During Hospitalization in Intensive Care Units Using AnapnoGuard 100 System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Hospitech Respiration · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hospitech Respiration Ltd has developed the AnapnoGuard system, an innovative system intended to enhance optimal endotracheal tube (ETT) cuff inflation, by monitoring carbon dioxide (CO2) in upper airways of mechanically ventilated patients. Optimal ETT cuff inflation will lead to a reduction of complication rate related to mechanical ventilation procedure. This study was design in order to evaluate the feasibility of using the AnapnoGuard system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AnapnoGuard 100 | Respiratory guard system during mechanical ventilation |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2010-08-25
- Last updated
- 2010-08-25
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT01188122. Inclusion in this directory is not an endorsement.